Zydus ties up with Apollo to expand cancer test access

Zydus ties up with Apollo to expand cancer test access — Zydus Lifesciences has signed an MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection (MCD) test across India. The collaboration aims to enhance early cancer screening in tier-2 and tier-3 cities. The test is currently available in 15 cities and plans to scale to 50 cities by 2027.

📊 STOCKS: ZYDUSLIFE | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Partnership